Internal Reference Number: FOI_6538
Date Request Received: 01/04/2022 00:00:00
Date Request Replied To: 21/04/2022 00:00:00
This response was sent via: By Email
Request Summary: Myelofibrosis
Request Category: Private Individuals
| Question Number 1: Does your trust treat myelofibrosis? If not, which other trust do you refer these patients to? | |
| Answer To Question 1: Our trust does treat myelofibrosis. | |
| Question Number 2: Please provide the total number of patients treated in the last 6 months (or the latest 6 months data you have available) for myelofibrosis (ICD10 code D47.4). | |
| Answer To Question 2: 15 | |
| Question Number 3: How many of these patients were above age 65? | |
| Answer To Question 3: 13 | |
| Question Number 4: How many myelofibrosis patients were treated in the past 6 months with Ruxolitinib? | |
| Answer To Question 4: In the past 6 months 7 patients were treated with ruxolitinib. | |
| Question Number 5: Of these patients, how many were treated in the past 6 months (or the latest 6 months data you have available) with: 鈥� Hydroxyurea 鈥� Fedratinib 鈥� Received No Treatment | |
| Answer To Question 5: Information not held with the trust | |
| Question Number 6: Does your trust participate in any clinical trials for the treatment of myelofibrosis? If so, can you please provide the name of each trial along with the number of patients taking part. | |
| Answer To Question 6: Our trust does not participate in clinical trials for treatment of myelofibrosis. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 看片软件 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
